Episode

611 - Bold Upgrades, Zero Downtime: How Smart Labs Are Modernising Pathology

Podcast
Talking HealthTech
Published
May 27, 2026
Duration seconds
2165
Processing state
not_requested
Canonical source
https://www.talkinghealthtech.com/podcast
Audio
https://pscrb.fm/rss/p/episodes.captivate.fm/episode/4b1eacc2-1d9a-497a-b20f-29e1da2039e4.mp3
JSON
/v1/public/podcasts/talking-healthtech-773483/episodes/611-bold-upgrades-zero-downtime-how-smart-labs-are-modernising-pathology
Markdown
/podcast/talking-healthtech-773483/611-bold-upgrades-zero-downtime-how-smart-labs-are-modernising-pathology.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/talking-healthtech-773483/episodes/611-bold-upgrades-zero-downtime-how-smart-labs-are-modernising-pathology/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/talking-healthtech-773483/611-bold-upgrades-zero-downtime-how-smart-labs-are-modernising-pathology.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

In this episode of Talking HealthTech, Peter Birch sits down with Dan Burke, Managing Director at Magentus, and Ben Richardson, CEO at Labflow, for a wide-ranging conversation about the state of pathology in Australia and the broader Asia-Pacific region. With half a billion pathology tests processed in Australia every year and a workforce of only 2,500 pathologists, the sector is under significant pressure. Dan and Ben unpack what that means for labs trying to modernise without disrupting the critical services that clinicians and patients depend on every day. The discussion covers the growing role of artificial intelligence in diagnostic settings, exploring where AI is already delivering practical value and where human oversight remains non-negotiable. The episode also digs into the challenge of legacy technology, making the case for incremental, modular modernisation over risky large-scale overhauls that can put operations at risk. Beyond the technology, the conversation explores how consumer expectations are reshaping pathology, from the direct-to-consumer testing boom across Asia-Pacific markets to the rise of genomics and personalised medicine. Key Takeaways 🔬 The pathology sector in Australia faces a significant workforce shortage and increasing test complexity, putting pressure on digital transformation in labs 🧩 Incremental modernisation and interoperability are addressed as more practical than full system replacements for pathology lab infrastructure 🧑‍⚕️ AI in diagnostics is positioned as a support tool for clinicians and administrative workflows, rather than replacing human experts 🌏 Consumer-driven demand, particularly in APAC markets like India and Malaysia, is accelerating digital adoption and expectations for health data access 🧬 The falling cost of genom…